 SEATTLE, May 20, 2021 GLOBE NEWSWIRE -- Adaptive Biotechnologies Corporation Nasdaq: ADPT a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will be participating virtually in the following investor conferences. 